Overview

Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Concentrations of voriconazole in pulmonary epithelial lining fluid and in serum are compared after inhalation of 40 mg voriconazole b.i.d. for two days or oral intake of voriconazole tablets 400 mg bid for 1 day followed by 200 mg b.i.d. for one day, respectively.
Phase:
N/A
Details
Lead Sponsor:
University of Aarhus
Collaborator:
Aarhus University Hospital
Treatments:
Voriconazole